COEP
Coeptis Therapeutics Holdings Inc
16.40
1 x 15.86
1 x 16.45
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd15.09%
1y31.52%
15.87
day range
17.27
0.13
52 week range
0.87
Open16.23Prev Close16.40Low15.87High17.27Mkt Cap5.74M
Vol111.93KAvg Vol517.73KEPS-0.28P/EN/AForward P/E-0.82
Beta-0.94Short Ratio0.40Inst. Own4.28%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg0.20200-d Avg0.261yr Est3.00
Income Statement
Total Revenue862.05K
Revenues (USD)862.05K
Cost of Revenue45.16K
Gross Profit816.89K
Operating Expenses2.81M
Research and Development Expense312.90K
Selling, General and Administrative Expense2.03M
Operating Income-1.99M
Interest Expense-105.14K
Net Income-1.58M
Net Income Common Stock-1.58M
Net Income Common Stock (USD)-1.58M
Consolidated Income-1.62M
Net Income to Non-Controlling Interests-45.03K
Earnings per Basic Share-0.12
Earnings per Basic Share (USD)-0.12
Earnings per Diluted Share-0.12
Earning Before Interest & Taxes (EBIT)-1.68M
Earning Before Interest & Taxes (USD)-1.68M
Weighted Average Shares4.23M
Weighted Average Shares Diluted4.23M
Balance Sheet
Cash and Equivalents5.67M
Cash and Equivalents (USD)5.67M
Investments8.54M
Investments Current676.60K
Investments Non-Current7.86M
Current Assets7.35M
Property, Plant & Equipment Net28.27K
Total Assets16.15M
Debt Current118.88K
Total Debt268.88K
Current Liabilities1.77M
Debt Non-Current150.00K
Total Liabilities2.09M
Accumulated Retained Earnings (Deficit)-109.95M
Shareholders Equity13.56M
Shareholders Equity (USD)13.56M
Assets Non-Current8.80M
Total Debt (USD)268.88K
Deposit Liabilities599.46K
Goodwill and Intangible Assets361.25K
Liabilities Non-Current317.63K
Trade and Non-Trade Payables888.76K
Cash Flow
Depreciation, Amortization & Accretion306.01K
Net Cash Flow from Financing2.45M
Net Cash Flow / Change in Cash & Cash Equivalents765.82K
Issuance (Purchase) of Equity Shares2.45M
Net Cash Flow from Operations-1.69M
Share Based Compensation213.91K